MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 552.42M
Enterprise Value 343.4M
Trailing P/E N/A
Forward P/E 1-2.58
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.72
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.86%
Return on Equity (ttm)-79.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.85M
Net Income Avi to Common (ttm)-13.99M
Diluted EPS (ttm)-0.5120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.78M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)213k
Total Debt/Equity (mrq)1.45
Current Ratio (mrq)1.49
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-13.24M
Levered Free Cash Flow (ttm)-5.18M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.24
52-Week Change 3-44.98%
S&P500 52-Week Change 34.08%
52 Week High 33.1500
52 Week Low 30.7772
50-Day Moving Average 31.2109
200-Day Moving Average 31.2545

Share Statistics

Avg Vol (3 month) 33.73M
Avg Vol (10 day) 3253.19k
Shares Outstanding 545.19M
Float 31.1M
% Held by Insiders 123.73%
% Held by Institutions 111.23%
Shares Short (May 31, 2019) 42.42M
Short Ratio (May 31, 2019) 41.88
Short % of Float (May 31, 2019) 48.83%
Short % of Shares Outstanding (May 31, 2019) 45.37%
Shares Short (prior month Apr 30, 2019) 43.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A